Concepedia

Namal P. M. Liyanage

NP

Statistics

Publications

20

Citations

739

H-Index

16

Active since

2007

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Walter Reed Army Institute of Research

The Ohio State University

Leidos (United States)

Namal P. M. Liyanage is an author at National Cancer Institute specializing in immunology, infectious diseases, and life sciences.

ORCID

Publications per year

2007–2022

20

Publications

20

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

Monica Vaccari, Shari N. Gordon, Slim Fourati et al. · Nature Medicine · 2016 · 204 citations · Full text

, , +16

HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition

Monica Vaccari, Slim Fourati, Shari N. Gordon et al. · Nature Medicine · 2018 · 76 citations · Full text

, , +13

<i>Helicobacter hepaticus</i> Cytolethal Distending Toxin Causes Cell Death in Intestinal Epithelial Cells via Mitochondrial Apoptotic Pathway

Namal P. M. Liyanage, Karoline C. Manthey, Rohana P. Dassanayake et al. · Helicobacter · 2010 · 46 citations · Full text

, , +16

Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology

No‐Joon Song, Carter Allen, Anna E. Vilgelm et al. · Journal of Hematology & Oncology · 2022 · 43 citations · Full text

, , +17

Antibody to the gp120 V1/V2 Loops and CD4+ and CD8+ T Cell Responses in Protection from SIVmac251 Vaginal Acquisition and Persistent Viremia

Shari N. Gordon, Melvin N. Doster, Rhonda C. Kines et al. · The Journal of Immunology · 2014 · 37 citations · Full text

, , +17

1–5 of 20